Earningsreport

Q3/2024 9/30/2024 EPS -0.370 ZacksConsensus -0.350 ActVsEst (0.020) - Miss

Actinium Pharmaceuticals, Inc. (Delaware)  (ATNM) 
NASDAQ:AMEX Investor Relations: ir.actiniumpharma.com